Pharma & Biotech Patent Litigation












Jane Lambert

For the second year running, I have been invited to address C5's annual conference on Pharma & Biotech Litigation.  That conference will take place at the Radisson Blu Hotel in Amsterdam between 26 and 27 Feb 2019.  Last year I discussed the Supreme Court's decision in  Eli Lilly v Actavis UK Ltd and others  [2017] Bus LR 1731, [2017] UKSC 48, [2017] RPC 21 with partners from the Dutch and German offices of DLA.  This year I shall be sharing a platform with Anna P. López Lozano who is head of IP at Esteve in Barcelona on the topic of Maximizing IP Regulatory Rights.  I shall be talking about supplementary protection certificates, a topic that I have recently addressed in the context of Brexit in Patents of there is no Deal 3 Oct 2018 NIPC Brexit.

Brexit is one of the key themes of the 2019 conference and there be a pre-conference workshop on the topic on 25 Feb 2019 entitled READY, STEADY, BREXIT: Identifying and Mitigating the Immediate Patent Litigation Risks for Life Sciences Companies.   Although I shall not be speaking from the platform I look forward to participating in the discussion of that topic from the floor.   Other key themes will be the trade secrets directive which is also one of my interests, functional patent claims and burden of proof analyses and digital concerns for the quality of patents.  There will also sessions focussing on litigation in China and the USA.

As a speaker, I can obtain a 10% discount on the conference fee for clients, contacts and colleagues.  Should any of my clients, colleagues in chambers, members of the IP Bar Association or other connections wish to take advantage of the entitlement they should contact my clerks, Tom or David, on +44 (0)20 7404 5252 as soon as possible.

An important cultural event coinciding with the conference will be the performance by the Dutch National Ballet of David Dawson's Requiem and Citizen of Nowhere on 27 Feb 2019.  Dawson, who happens to be British, is one of the outstanding choreographers of our age and the Dutch National Ballet is one of the world's leading companies.  The performing arts are one of my abiding passions and I attend a lot of ballets, plays, operas and concerts every year as well as blog about dance in Terpsichore. I have yet to see a finer company in the world.

Comments

Popular posts from this blog

Learning the Law at St Andrews - Mooting

IP and Brexit: the Fashion Industry

Perhaps the Most Complex World IP Day Theme Ever